Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis

Experimental Dermatology

Volumn 14, Issue 7, 2005, Pages 543-550

  Willers, Jörg ^a   Lucchese, Alberta ^b   Mittelman, Abraham ^c   Dummer, Reinhard ^a   Kanduc, Darja ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BARI   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Epitope prediction; Melanoma; Similarity level; Tyrosinase; Vitiligo

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; MONOPHENOL MONOOXYGENASE; PROTEOME;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COMPUTER ANALYSIS; CONTROLLED STUDY; ENZYME ANALYSIS; HOST; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MELANOCYTE; MELANOMA; METHODOLOGY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VITILIGO; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; EPITOPE MAPPING; EPITOPES; H-2 ANTIGENS; HUMANS; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; PEPTIDE FRAGMENTS; PROTEOMICS;

EID: 21244498559     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00327.x     Document Type: Article

References (39)

1. Brinkman J A, Fausch S C, Weber J S, Kast W M. Peptide-based vaccines for cancer immunotherapy. Expert Opin Biol Ther 2004: 4: 181-198.
2. Monneaux F, Muller S. Peptide-based immunotherapy of systemic lupus erythematosus. Autoimmun Rev 2004: 3: 16-24.
3. Alexander C, Kay A B, Larche M. Peptide-based vaccines in the treatment of specific allergy. Curr Drug Targets Inflamm Allergy 2002: 1: 353-361.
4. Mei Y, Beers K L, Byrd H C, VanderHart D L, Washburn N R. Solid-phase ATRP synthesis of peptide-polymer hybrids. J Am Chem Soc 2004: 126: 3472-3476.
5. Rosenbaum D M, Liu D R. Efficient and sequence-specific DNA-templated polymerization of peptide nucleic acid aldehydes. J Am Chem Soc 2003: 125: 13924-13925.
6. Le Gal F A, Prevost-Blondel A, Lengagne R et al. Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study. Int J Cancer 2002: 98: 221-227.
7. Willers J, Lucchese A, Kanduc D, Ferrone S. Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside. Peptides 1999: 20: 1021-1026.
8. Ashok B T, David L, Chen Y G et al. Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. Int J Mol Med 2003: 11: 465-471.
9. Kanduc D, Capuano F, Capurso S A et al. Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol 2003: 3: 108-114.
10. Kozhich A T, Caspi R R, Berzofsky J A, Gery I. Immunogenicity and immunopathogenicity of an autoimmune epitope are potentiated by increasing MHC binding through residue substitution. J Immunol 1997: 158: 4145-4151.
11. Ferlin W G, Mougneau E, Hugues S et al. Self-peptides that bind with low affinity to the diabetes-associated I-A (g7) molecule readily induce T cell tolerance in non-obese diabetic mice. Eur J Immunol 2004: 34: 2656-2663.
12. Belmares M P, Busch R, Wucherpfennig K W, McConnell H M, Mellins E D. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J Immunol 2002: 169: 5109-5117.
13. Mocellin S, Rossi C R, Nitti D, Lise M, Marincola F M. Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. Biochim Biophys Acta 2003: 1653: 61-71.
14. Salazar L G, Fikes J, Southwood S et al. Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles. Clin Cancer Res 2003: 9: 5559-5565.
15. Kanduc D, Fanizzi F P, Lucchese G, Stefanovic S, Sinha A A, Mittelman A. NMR probing of in silico identification of anti-HPV16 E7 MAb linear peptide epitope. Peptides 2004: 25: 243-250.
16. Mittelman A, Tiwari R, Lucchese G, Willers J, Dummer R, Kanduc D. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining. J Invest Dermatol 2004: 123: 670-675.
17. Mittelman A, Lucchese A, Sinha A A, Kanduc D. Monoclonal and polyclonal humoral immune response to EC HER-2/neu peptides with low similarity to the host's proteome. Int J Cancer 2002: 98: 741-747.
18. Dummer R, Mittelman A, Fanizzi F P, Lucchese G, Willers J, Kanduc D. Non-self discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients. Int J Cancer 2004: 111: 720-726.
19. Lane C, Leitch J, Tan X, Hadjati J, Bramson J L, Wan Y. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res 2004: 64: 1509-1514.
20. Kemp E H, Waterman E A, Weetman A P. Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 2001, 1-22.
21. Rammensee H, Bachmann J, Emmerich N P, Bachor O A, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999: 50: 213-219.
22. Wu C H, Huang H, Arminski L et al. The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res 2002: 30: 35-37.
23. Chen Y T, Stockert E, Tsang S, Coplan K A, Old L J. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci U S A 1995: 92: 8125-8129.
24. Margalit H, Spouge J L, Cornette J L, Cease K B, Delisi C, Berzofsky J A. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol 1987: 138: 2213-2229.
25. Spouge J L, Guy H R, Cornette J L et al. Strong conformational propensities enhance T cell antigenicity. J Immunol 1987: 138: 204-212.
26. Hopp T P, Woods K R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 1981: 78: 3824-3828.
27. Reyes V E, Lew R A, Lu S, Humphreys R E. Prediction of alpha helices and T cell-presented sequences in proteins with algorithms based on strip-of-helix hydrophobicity index. Methods Enzymol 1991: 202: 225-238.
28. Lamas J R, Brooks J M, Galocha B, Rickinson A B, Lopez de Castro J A. Relationship between peptide binding and T cell epitope selection: a study with sub-types of HLA-B27. Int Immunol 1998: 10: 259-266.
29. Van Regenmortel M H V. Transcending the structuralist paradigm in unmunology. Affinity and biological activity rather than purely structural considerations should guide the design of synthetic peptide epitopes. Biomed Pept Proteins Nucleic Acids 1995: 1: 109-116.
30. Van Regenmortel M H V. Reductionism and the search for structure-function relationships in antibody molecules. J Mol Recognit 2002: 15: 240-247.
31. Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between HPV16 E7 oncoprotein and human protein sequences. Immunol Cell Biol 2000: 78: 580-585.
32. Kanduc D, Lucchese A, Mittelman A. Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology. Peptides 2001: 22: 1981-1985.
33. Jaanson N, Moll K, Kulla A, Ustav M. Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies. Melanoma Res 2003: 13: 473-482.
34. Bankovich A J, Garcia K C. Not just any T cell receptor will do. Immunity 2003: 18: 7-11.
35. Wu B, Toussaint G, Vander Elst L, Granier C, Jacquemin M G, Saint-Remy J M. Major T cell epitope-containing peptides can elicit strong antibody responses. Eur J Immunol 2000: 30: 291-299.
36. Vrtala S, Akdis C A, Budak F et al. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol 2000 165: 6653-6659.
37. Forsthuber T G, Shive C L, Wienhold W et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol 2001: 167: 7119-7125.
38. Ghosh S, Walker J, Jackson D C. Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus. Immunology 2001: 104: 58-66.
39. Kaliyaperumal A, Michaels M A, Datta S K. Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol 2002: 168: 2530-2537.